Eidos Therapeutics
Get verified emails for Eidos Therapeutics employees
About Eidos Therapeutics
|
|
|
51-200 employees
View all
|
|
Biotechnology
|
|
101 Montgomery St,San Francisco,California,US
|
|
Eidos Therapeutics, a subsidiary of BridgeBio Pharma, is developing AG10 as a targeted therapeutic for transthyretin amyloidosis. The company’s singular mission is to improve and prolong the lives of patients suffering from this disease.
Launched in 2016 after years of research supported by Stanford’s SPARK program, Eidos is led by a team of veteran biotechnology executives. Together with patients and physicians, the company aims to bring a safe, effective treatment to market as quickly as possible.
|
Eidos Therapeutics Email Format
The widely used Eidos Therapeutics email format is {f}{last}@eidostx.com (e.g. [email protected]), which is used 75.00% of the time.
| Eidos Therapeutics Email Formats | Example Email Formats | Percentage |
|---|---|---|
| {f}{last} | [email protected] |
75.00%
|
Eidos Therapeutics Alternatives
Frequently Asked Questions about Eidos Therapeutics
What is Eidos Therapeutics email format?
The widely used Eidos Therapeutics email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
What is Eidos Therapeutics customer service number?
To contact Eidos Therapeutics customer service number in your country click here to find.
Eidos Therapeutics Staff Directory
Search Eidos Therapeutics Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Search Portal
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.
